Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

Yu,Minhao; Zhong,Ming; Qiao,Zhongdong

doi:10.3892/ol.2013.1456

September 2013 Volume 6 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September 2013 Volume 6 Issue 3

Full Size Image

Article

Expression and clinical significance of cyclin kinase subunit 2 in colorectal cancer

Authors:
- Minhao Yu
- Ming Zhong
- Zhongdong Qiao
View Affiliations / Copyright

Affiliations: Department of Surgery, Renji Hospital, Shanghai Jiaotong University, Shanghai 200127, P.R. China
Pages: 777-780
|
Published online on: July 11, 2013

https://doi.org/10.3892/ol.2013.1456
Expand metrics +

Abstract

The overexpression of cyclin kinase subunit 2 (CKS2) is tightly correlated with tumor aggressiveness and prognosis in various malignancies, including gastric, breast, liver and prostate cancer. However, whether CKS2 is upregulated in colorectal cancer (CRC) remains unknown. The aim of the present study was to analyze CKS2 expression levels in CRC, and to determine the clinical diagnostic and prognostic values of CKS2 overexpression in CRC patients. CKS2 expression was analyzed at the mRNA and protein levels by quantitative (q)PCR and western blot analysis. CKS2 expression was significantly upregulated in CRC compared with the adjacent non‑cancer and normal colorectal tissues. The overexpression of CKS2 was correlated with poor differentiation and the pathological stage. In addition, CKS2 overexpression was correlated with aggressive tumor progression in CRC, which indicated that CKS2 may serve as a good CRC biomarker.

View Figures

View References

1	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
2	Edge SB: AJCC Staging Manual. 7th edition. Springer; New York, NY: 2010
3	Le Voyer TE, Sigurdson ER, Hanlon AL, et al: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survery of intergroup trial INT-0089. J Clin Oncol. 21:2912–2919. 2003.
4	Siena S, Sartore-Bianchi A, Di Nicolantonio F, et al: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 101:1308–1324. 2009. View Article : Google Scholar : PubMed/NCBI
5	Chu DZ, Erickson CA, Russell MP, et al: Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence. Arch Surg. 126:314–316. 1991. View Article : Google Scholar : PubMed/NCBI
6	Williams RT, Wu L, Carbonaro-Hall DA, et al: Identification of a novel cyclin-like protein in human tumor cells. J Biol Chem. 268:8871–8880. 1993.PubMed/NCBI
7	Slotky M, Shapira M, Ben-Izhak O, et al: The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Breast Cancer Res. 7:R737–R744. 2005. View Article : Google Scholar : PubMed/NCBI
8	Shapira M, Ben-Izhak O, Linn S, et al: The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Cancer. 103:1336–1346. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lan Y, Zhang Y, Wang J, et al: Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer. 123:543–551. 2008. View Article : Google Scholar : PubMed/NCBI
10	Liu Z, Fu Q, Lv J, Wang F and Ding K: Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. J Exp Clin Cancer Res. 27:512008. View Article : Google Scholar : PubMed/NCBI
11	Kawakami K, Enokida H, Tachiwada T, et al: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep. 16:521–531. 2006.PubMed/NCBI
12	Kang MA, Kim JT, Kim JH, et al: Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol. 135:761–769. 2009. View Article : Google Scholar : PubMed/NCBI
13	Shen DY, Fang ZX, You P, et al: Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 30:119–125. 2009. View Article : Google Scholar : PubMed/NCBI
14	Alhasan SA, Ensley JF, Sarkar FH, et al: Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol. 16:333–338. 2000.PubMed/NCBI
15	Hansel DE, Dhara S, Huang RC, et al: CDC2/CDK1 expression in esophageal adenocarcinoma and precursor lesions serves as a diagnostic and cancer progression marker and potential novel drug target. Am J Surg Pathol. 29:390–399. 2005. View Article : Google Scholar
16	Martinsson-Ahlzén HS, Liberal V, Grünenfelder B, et al: Cyclin-dependent kinase-associated proteins Cks1 and Cks2 are essential during early embryogenesis and for cell cycle progression in somatic cells. Mol Cell Biol. 28:5698–5709. 2008.